|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35|36 |37 |38 |39 |40 |41 |42 |43 |44 |45 |46 |47 |48 |49 |50 |51 |52 |53 |54 |55 |56 |57 |58 |59 |60 |61 |62 |63 |64 |65 |review |
 |
1.The
apparent benefits in terms of reduced risk of cardiovascular events
associated with high dose statin therapy need to be viewed in the
context of higher risk of side effects.
2.While
the event rates are low, there is clear evidence of hepatotoxicity
associated with high-dose statin use.
|